Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours
- 24 Juillet 2024 - 1 mn de lecture
The purpose of the protocol is to determine safety, tolerability, recommended dose (RD), pharmacokinetics (PK), pharmacodynamics (PD) and preliminary anti-tumour activity of IPN60090 as a single agent (Part A) and in combination with pembrolizumab (Part B) or paclitaxel (Part C) in patients with advanced solid tumours and to evaluate food effect (Part D).
24 Juillet 2024
1 mn de lecture
A study to evaluate the effect of phenytoin or itraconazole on the circulating levels of IPN60130 in healthy adult participants
24 Juillet 2024
1 mn de lecture
A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ?14 Years With Fibrodysplasia Ossificans Progressiva...
24 Juillet 2024
1 mn de lecture
A study to assess whether adding maintenance cabozantinib (XL184) to best supportive care helps children, adolescents and young adults with osteosarcoma.
24 Juillet 2024
2 mn de lecture
A study to evaluate the effectiveness and safety of Dysport® for the prevention of episodic migraine in adults
24 Juillet 2024
2 mn de lecture
A study to evaluate the effectiveness and safety of Dysport® for the prevention of chronic migraine in adults
24 Juillet 2024
1 mn de lecture
A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.
24 Juillet 2024
2 mn de lecture
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
24 Juillet 2024
2 mn de lecture
Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumours
24 Juillet 2024
1 mn de lecture
Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia
24 Juillet 2024
1 mn de lecture